These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19547700)

  • 1. Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold.
    Nakamuta JS; Danoviz ME; Marques FL; dos Santos L; Becker C; Gonçalves GA; Vassallo PF; Schettert IT; Tucci PJ; Krieger JE
    PLoS One; 2009 Jun; 4(6):e6005. PubMed ID: 19547700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rat adipose tissue-derived stem cells transplantation attenuates cardiac dysfunction post infarction and biopolymers enhance cell retention.
    Danoviz ME; Nakamuta JS; Marques FL; dos Santos L; Alvarenga EC; dos Santos AA; Antonio EL; Schettert IT; Tucci PJ; Krieger JE
    PLoS One; 2010 Aug; 5(8):e12077. PubMed ID: 20711471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction.
    Yoshizumi T; Zhu Y; Jiang H; D'Amore A; Sakaguchi H; Tchao J; Tobita K; Wagner WR
    Biomaterials; 2016 Mar; 83():182-93. PubMed ID: 26774561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction.
    Li Y; Yao Y; Sheng Z; Yang Y; Ma G
    Int J Nanomedicine; 2011; 6():815-23. PubMed ID: 21589649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction.
    Tossios P; Krausgrill B; Schmidt M; Fischer T; Halbach M; Fries JW; Fahnenstich S; Frommolt P; Heppelmann I; Schmidt A; Schomäcker K; Fischer JH; Bloch W; Mehlhorn U; Schwinger RH; Müller-Ehmsen J
    Eur Heart J; 2008 Aug; 29(15):1911-21. PubMed ID: 18544545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac effects of experimental intravenous bone marrow cell transplantation after myocardial infarction.
    Holinski S; Heinze G; Knebel F; Borges AC; Baumann G; Rudolph B; Konertz W
    Ann Thorac Cardiovasc Surg; 2012; 18(5):452-7. PubMed ID: 22673555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of bone marrow cell therapy is more important than repeated injections after myocardial infarction.
    Zhang Y; Sievers RE; Prasad M; Mirsky R; Shih H; Wong ML; Angeli FS; Ye J; Takagawa J; Koskenvuo JW; Springer ML; Grossman W; Boyle AJ; Yeghiazarians Y
    Cardiovasc Pathol; 2011; 20(4):204-12. PubMed ID: 20667749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-Related Impaired Efficacy of Bone Marrow Cell Therapy for Myocardial Infarction Reflects a Decrease in B Lymphocytes.
    An S; Wang X; Ruck MA; Rodriguez HJ; Kostyushev DS; Varga M; Luu E; Derakhshandeh R; Suchkov SV; Kogan SC; Hermiston ML; Springer ML
    Mol Ther; 2018 Jul; 26(7):1685-1693. PubMed ID: 29914756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection of Peptide nanogels preserves postinfarct diastolic function and prolongs efficacy of cell therapy in pigs.
    Lin YD; Chang MY; Cheng B; Liu YW; Lin LC; Chen JH; Hsieh PC
    Tissue Eng Part A; 2015 May; 21(9-10):1662-71. PubMed ID: 25686878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials.
    Forest VF; Tirouvanziam AM; Perigaud C; Fernandes S; Fusellier MS; Desfontis JC; Toquet CS; Heymann MF; Crochet DP; Lemarchand PF
    Stem Cell Res Ther; 2010 Mar; 1(1):4. PubMed ID: 20504285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery.
    Li SH; Lai TY; Sun Z; Han M; Moriyama E; Wilson B; Fazel S; Weisel RD; Yau T; Wu JC; Li RK
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1225-33.e1. PubMed ID: 19379996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model.
    Wang W; Jiang Q; Zhang H; Jin P; Yuan X; Wei Y; Hu S
    Regen Med; 2011 Mar; 6(2):179-90. PubMed ID: 21391852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-targeted microbubble destruction enhances delayed BMC delivery and attenuates post-infarction cardiac remodelling by inducing engraftment signals.
    Chen Y; Zhang C; Shen S; Guo S; Zhong L; Li X; Chen G; Chen G; He X; Huang C; He N; Liao W; Liao Y; Bin J
    Clin Sci (Lond); 2016 Dec; 130(23):2105-2120. PubMed ID: 27609823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eNOS overexpressing bone marrow cells are safe and effective in a porcine model of myocardial regeneration following acute myocardial infarction.
    Ward MR; Connelly KA; Vijayaraghavan R; Vaags AK; Graham JJ; Foltz W; Hough MR; Stewart DJ; Dick A
    Cardiovasc Ther; 2013 Dec; 31(6):e72-8. PubMed ID: 23837864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery route in bone marrow cell transplantation should be optimized according to the etiology of heart disease.
    Nakajima H; Sakakibara Y; Tambara K; Marui A; Yoshimoto M; Premaratne GU; Lin X; Kanemitsu N; Sakaguchi G; Ikeda T; Nishimura K; Nakahata T; Komeda M
    Circ J; 2008 Sep; 72(9):1528-35. PubMed ID: 18724034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent availability and functionality of bone marrow stem cells in an experimental model of acute and chronic myocardial infarction.
    Ayala-Lugo A; Tavares AM; Paz AH; Alegretti A; Miquelito L; Bock H; Giugliani R; Clausell N; Cirne-Lima E; Rohde LE
    Cell Transplant; 2011; 20(3):407-19. PubMed ID: 21535915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs.
    Lin YD; Yeh ML; Yang YJ; Tsai DC; Chu TY; Shih YY; Chang MY; Liu YW; Tang AC; Chen TY; Luo CY; Chang KC; Chen JH; Wu HL; Hung TK; Hsieh PC
    Circulation; 2010 Sep; 122(11 Suppl):S132-41. PubMed ID: 20837904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction.
    Jain M; DerSimonian H; Brenner DA; Ngoy S; Teller P; Edge AS; Zawadzka A; Wetzel K; Sawyer DB; Colucci WS; Apstein CS; Liao R
    Circulation; 2001 Apr; 103(14):1920-7. PubMed ID: 11294813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary stem-cell injection after myocardial infarction: microcirculation sub-study.
    Moreira Rde C; Haddad AF; Silva SA; Souza AL; Tuche FA; Oliveira MA; Mesquita CT; Rochitte CE; Borojevic R; Dohmann HF
    Arq Bras Cardiol; 2011 Nov; 97(5):420-6. PubMed ID: 22193396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction.
    Beeres SL; Bax JJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
    Am J Cardiol; 2007 Oct; 100(7):1094-8. PubMed ID: 17884369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.